Ultragenyx Pharmaceutical Inc. (RARE) stock
RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.73+1.03 (+6.17%)
Close on Nov 18, 2026Market cap $1.75BP/E –Yield –
Ultragenyx Pharmaceutical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?